{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:58:41Z","timestamp":1790841521010,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Regenerative capacity and inflammatory responses are key determinants of outcome in acute liver failure (ALF). However, their prognostic significance in non\u2010acetaminophen drug\u2010induced liver injury with acute liver injury or ALF (non\u2010APAP\u2010DILI\u2010ALI\/ALF) remains poorly defined. We aimed to identify biomarkers of regeneration and inflammation associated with clinical outcomes in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated clinical laboratory parameters and circulating biomarkers in 79 patients with non\u2010APAP\u2010DILI\u2010ALI\/ALF (20 with ALI, 59 with ALF) and 19 healthy donors. We used multivariable logistic regression to identify independent predictors of 21\u2010day transplant\u2010free survival among these patients. These predictors were used to create a composite model that was compared with the Model for End\u2010Stage Liver Disease (MELD) score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Markers reflecting hepatic synthetic dysfunction (TBIL, INR, MELD) were strongly associated with the outcomes, whereas aminotransferases were not. HGF levels were markedly elevated in non\u2010APAP\u2010DILI\u2010ALI\/ALF patients versus healthy donors (5070\u2009\u00b1\u20094001 vs. 276\u2009\u00b1\u2009581\u2009pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), increased with injury severity, and were highest in patients who died or underwent transplantation (6421\u2009\u00b1\u20094359 vs. 4102\u2009\u00b1\u20093456\u2009pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). Among inflammatory mediators, only interleukin\u20106 showed a modest association with outcome. We developed an H\u2010Score based on the three variables independently associated with survival on multivariable analysis: HGF (odds ratio, 1.0002;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048), TBIL and INR. The H\u2010Score outperformed MELD overall (area under the curve, 0.819 vs. 0.713) and in ALF only patients (0.811 vs. 0.643;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.040).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HGF provides independent prognostic value beyond standard measures in non\u2010APAP\u2010DILI\u2010ALF. The H\u2010Score may improve risk stratification over the MELD score and warrants validation in a prospective cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/liv.70895","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:23:01Z","timestamp":1790839381000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Hepatocyte Growth Factor Predicts Outcomes in Non\u2010Acetaminophen Drug\u2010Induced Acute Liver Failure"],"prefix":"10.1111","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-3430","authenticated-orcid":false,"given":"Tao","family":"Wang","sequence":"first","affiliation":[{"name":"Office of Pharmaceutical Quality Research Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M.","family":"Bacot","sequence":"additional","affiliation":[{"name":"Office of Pharmaceutical Quality Research Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamai","family":"Patterson","sequence":"additional","affiliation":[{"name":"Office of Pharmaceutical Quality Research Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devira","family":"Friedman","sequence":"additional","affiliation":[{"name":"Office of Pharmaceutical Quality Research Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Taylor","sequence":"additional","affiliation":[{"name":"Office of Pharmaceutical Quality Research Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiao","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Bioinformatics and Biostatistics National Center for Toxicological Research, U.S. Food and Drug Administration  Jefferson Arkansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Bioinformatics and Biostatistics National Center for Toxicological Research, U.S. Food and Drug Administration  Jefferson Arkansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5535-7996","authenticated-orcid":false,"given":"Mark I.","family":"Avigan","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-1020","authenticated-orcid":false,"given":"Paul","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Hepatology and Nutrition Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-372X","authenticated-orcid":false,"given":"Jody A.","family":"Rule","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology University of Texas Southwestern  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2783-5441","authenticated-orcid":false,"given":"William M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology University of Texas Southwestern  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-9779","authenticated-orcid":false,"given":"Jorge","family":"Rakela","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Mayo Clinic  Phoenix Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald M.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Office of Pharmaceutical Quality Research Center for Drug Evaluation and Research, U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6453-2351","authenticated-orcid":false,"given":"Minjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Bioinformatics and Biostatistics National Center for Toxicological Research, U.S. Food and Drug Administration  Jefferson Arkansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"5","key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the Management of Acute (Fulminant) Liver Failure","volume":"66","author":"Wendon J.","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"10201","key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute Liver Failure","volume":"394","author":"Stravitz R. T.","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug\u2010Induced Liver Injury","volume":"5","author":"Andrade R. J.","year":"2019","journal-title":"Nature Reviews Disease Primers"},{"issue":"12","key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States","volume":"137","author":"Ostapowicz G.","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cld.2019.09.005","article-title":"Acute Liver Failure Secondary to Drug\u2010Induced Liver Injury","volume":"24","author":"Chayanupatkul M.","year":"2020","journal-title":"Clinics in Liver Disease"},{"issue":"1","key":"e_1_2_12_7_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug\u2010Induced Liver Injury Network (DILIN) Prospective Study","volume":"32","author":"Fontana R. J.","year":"2009","journal-title":"Drug Safety"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2024.101968","article-title":"Liver Transplantation in Acute Liver Failure","volume":"73","author":"Ichai P.","year":"2024","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"issue":"8","key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver Transplantation for Acute Liver Failure From Drug Induced Liver Injury in the United States","volume":"10","author":"Russo M. W.","year":"2004","journal-title":"Liver Transplantation"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2024.101957","article-title":"Prognostic Models in Acute Liver Failure\u2010Historic Evolution and Newer Updates \u201cPrognostic Models in Acute Liver Failure\u201d","volume":"73","author":"Panackel C.","year":"2024","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"issue":"9","key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/14737159.2018.1508998","article-title":"Biomarkers of Drug\u2010Induced Liver Injury: Progress and Utility in Research, Medicine, and Regulation","volume":"18","author":"McGill M. R.","year":"2018","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"2","key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate Biomarkers for the Diagnosis and Prognosis of Drug\u2010Induced Liver Injury: An International Collaborative Effort","volume":"69","author":"Church R. J.","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/HEP.0000000000000458","article-title":"Future Directions in Acute Liver Failure","volume":"78","author":"Stravitz R. T.","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jhep.2020.06.005","article-title":"Model for End\u2010Stage Liver Disease\u2010Sodium Underestimates 90\u2010Day Mortality Risk in Patients With Acute\u2010on\u2010Chronic Liver Failure","volume":"73","author":"Hernaez R.","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"3","key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/hep.21503","article-title":"MELD Score as a Predictor of Liver Failure and Death in Patients With Acetaminophen\u2010Induced Liver Injury","volume":"45","author":"Schmidt L. E.","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"e_1_2_12_16_1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cgh.2012.02.016","article-title":"Etiologies and Outcomes of Acute Liver Failure in Germany","volume":"10","author":"Hadem J.","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"9","key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/14728222.2016.1162293","article-title":"Hepatocyte Growth Factor and Alternative Splice Variants\u2014Expression, Regulation and Implications in Osteogenesis and Bone Health and Repair","volume":"20","author":"Frisch R. N.","year":"2016","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.808855","article-title":"HGF\/c\u2010Met: A Key Promoter in Liver Regeneration","volume":"13","author":"Zhao Y.","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"e_1_2_12_19_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.1840210119","article-title":"Serum Hepatocyte Growth Factor Levels in Liver Diseases: Clinical Implications","volume":"21","author":"Shiota G.","year":"1995","journal-title":"Hepatology"},{"issue":"13","key":"e_1_2_12_20_1","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.0306068101","article-title":"Hepatocyte Growth Factor\/c\u2010Met Signaling Pathway Is Required for Efficient Liver Regeneration and Repair","volume":"101","author":"Huh C.\u2010G.","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1083\/jcb.119.3.629","article-title":"Hepatocyte Growth Factor Is a Potent Angiogenic Factor Which Stimulates Endothelial Cell Motility and Growth","volume":"119","author":"Bussolino F.","year":"1992","journal-title":"Journal of Cell Biology"},{"issue":"1","key":"e_1_2_12_22_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1440-1746.2010.06549.x","article-title":"Hepatocyte Growth Factor Twenty Years on: Much More Than a Growth Factor","volume":"26","author":"Nakamura T.","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"e_1_2_12_23_1","doi-asserted-by":"crossref","DOI":"10.3390\/cells12020208","article-title":"Role of Hepatocyte Growth Regulators in Liver Regeneration","volume":"12","author":"Kimura M.","year":"2023","journal-title":"Cells"},{"issue":"1","key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(05)80475-1","article-title":"Plasma Hepatocyte Growth Factor and Biliprotein Levels and Outcome in Fulminant Hepatic Failure","volume":"20","author":"Hughes R. D.","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"43","key":"e_1_2_12_25_1","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.1073\/pnas.0704126104","article-title":"The EGF Receptor Is Required for Efficient Liver Regeneration","volume":"104","author":"Natarajan A.","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"e_1_2_12_26_1","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1038\/s41598-021-92888-4","article-title":"Influence of Cytokines, Circulating Markers and Growth Factors on Liver Regeneration and Post\u2010Hepatectomy Liver Failure: A Systematic Review and Meta\u2010Analysis","volume":"11","author":"Murtha\u2010Lemekhova A.","year":"2021","journal-title":"Scientific Reports"},{"issue":"5","key":"e_1_2_12_27_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101338","article-title":"Serum Proteomics of Adults With Acute Liver Failure Provides Mechanistic Insights and Attractive Prognostic Biomarkers","volume":"7","author":"Remih K.","year":"2025","journal-title":"JHEP Reports"},{"issue":"5","key":"e_1_2_12_28_1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2008.08.009","article-title":"The Importance of Immune Dysfunction in Determining Outcome in Acute Liver Failure","volume":"49","author":"Antoniades C. G.","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"10","key":"e_1_2_12_29_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206389","article-title":"Cytokine Profiles in Acute Liver Injury\u2010Results From the US Drug\u2010Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group","volume":"13","author":"Bonkovsky H. L.","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"e_1_2_12_30_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0167-4889(02)00326-9","article-title":"The Role of Cytokines in Liver Failure and Regeneration: Potential New Molecular Therapies","volume":"1592","author":"Galun E.","year":"2002","journal-title":"Biochimica et Biophysica Acta, Molecular Cell Research"},{"key":"e_1_2_12_31_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-9-55","article-title":"Safety and Pharmacokinetics of Recombinant Human Hepatocyte Growth Factor (Rh\u2010HGF) in Patients With Fulminant Hepatitis: A Phase I\/II Clinical Trial, Following Preclinical Studies to Ensure Safety","volume":"9","author":"Ido A.","year":"2011","journal-title":"Journal of Translational Medicine"},{"issue":"6","key":"e_1_2_12_32_1","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug\u2010Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study","volume":"52","author":"Reuben A.","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"e_1_2_12_33_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/cld.219","article-title":"Acute Liver Failure: Peritransplant Management and Outcomes","volume":"2","author":"Fix O. K.","year":"2013","journal-title":"Clinical Liver Disease (Hoboken)"},{"issue":"4","key":"e_1_2_12_34_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.14309\/ajg.0000000000001655","article-title":"Secular Trends in Severe Idiosyncratic Drug\u2010Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry","volume":"117","author":"Rao A.","year":"2022","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1503\/cjs.007911","article-title":"Effect of Different Liver Resection Methods on Liver Damage and Regeneration Factors VEGF and FGF\u20102 in Mice","volume":"55","author":"B\u00f6nninghoff R.","year":"2012","journal-title":"Canadian Journal of Surgery"},{"issue":"2","key":"e_1_2_12_36_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(97)00078-2","article-title":"Density\u2010Dependent Proliferation of Adult Rat Hepatocytes in Primary Culture Induced by Epidermal Growth Factor Is Potentiated by cAMP\u2010Elevating Agents","volume":"324","author":"Kimura M.","year":"1997","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"e_1_2_12_37_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12893-019-0664-8","article-title":"Markers of Liver Regeneration\u2014The Role of Growth Factors and Cytokines: A Systematic Review","volume":"20","author":"Hoffmann K.","year":"2020","journal-title":"BMC Surgery"},{"issue":"3","key":"e_1_2_12_38_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/15476910903501748","article-title":"Cytokine and Autoantibody Patterns in Acute Liver Failure","volume":"7","author":"Li J.","year":"2010","journal-title":"Journal of Immunotoxicology"},{"issue":"12","key":"e_1_2_12_39_1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cgh.2007.08.007","article-title":"Serum Apoptosis Markers in Acute Liver Failure: A Pilot Study","volume":"5","author":"Rutherford A. E.","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"60","key":"e_1_2_12_40_1","first-page":"1667","article-title":"Interleukin\u20106 Augments Hepatocyte Growth Factor\u2010Induced Liver Regeneration; Involvement of STAT3 Activation","volume":"51","author":"Kaido T.","year":"2004","journal-title":"Hepato\u2010Gastroenterology"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70895","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/liv.70895","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:23:06Z","timestamp":1790839386000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.70895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1111\/liv.70895"],"URL":"https:\/\/doi.org\/10.1111\/liv.70895","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"2026-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70895"}}